Share on StockTwits
 

CONMED Corp. (NASDAQ:CNMD) released its earnings data on Thursday. The company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.04, Stock Ratings News reports. The company had revenue of $203.40 million for the quarter, compared to the consensus estimate of $197.24 million.

A number of research firms have recently commented on CNMD. Analysts at Needham & Company raised their price target on shares of CONMED Corp. from $45.00 to $48.00 in a research note on Tuesday. They now have a “buy” rating on the stock. Finally, analysts at Zacks reiterated a “neutral” rating on shares of CONMED Corp. in a research note on Monday, November 25th. They now have a $41.00 price target on the stock.

Shares of CONMED Corp. (NASDAQ:CNMD) opened at 45.62 on Thursday. CONMED Corp. has a 1-year low of $29.10 and a 1-year high of $45.72. The stock’s 50-day moving average is $42.90 and its 200-day moving average is $37.29. The company has a market cap of $1.260 billion and a P/E ratio of 34.55.

CONMED Corporation (NASDAQ:CNMD) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.